Cargando…
Comprehensive characterization of FBXW7 mutational and clinicopathological profiles in human colorectal cancers
BACKGROUND: FBXW7 is recognized as a critical tumor suppressor gene and a component of the ubiquitin-proteasome system, mediating the degradation of multiple oncogenic proteins, including c-MYC, Cyclin E, c-Jun, Notch, p53. Around 16% of colorectal cancer (CRC) patients carried FBXW7 somatic mutatio...
Autores principales: | Liu, Yiping, Chen, Hanlin, Bao, Hua, Zhang, Jinfeng, Wu, Runda, Zhu, Lingjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091464/ https://www.ncbi.nlm.nih.gov/pubmed/37064111 http://dx.doi.org/10.3389/fonc.2023.1154432 |
Ejemplares similares
-
FBXW7 and the Hallmarks of Cancer: Underlying Mechanisms and Prospective Strategies
por: Shen, Wenyue, et al.
Publicado: (2022) -
FBXW7 and Its Downstream NOTCH Pathway Could be Potential Indicators of Organ-Free Metastasis in Colorectal Cancer
por: Li, Dongzheng, et al.
Publicado: (2022) -
Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy
por: Xing, Liangliang, et al.
Publicado: (2022) -
FBXW7 attenuates tumor drug resistance and enhances the efficacy of immunotherapy
por: Chen, Shimin, et al.
Publicado: (2023) -
Intratumor Heterogeneity of MYO18A and FBXW7 Variants Impact the Clinical Outcome of Stage III Colorectal Cancer
por: Lin, Peng-Chan, et al.
Publicado: (2020)